# Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

> **NCT02302742** · — · RECRUITING · sponsor: **University of Kansas Medical Center** · enrollment: 1500 (estimated)

## Conditions studied

- Breast Cancer
- Hereditary Breast and Ovarian Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02302742
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2011-03-22
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02302742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02302742, "Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02302742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*